Article Versions Notes

Amaral T, Seeber O, Mersi E, Sanchez S, Thomas I, Meiwes A, Forschner A, Leiter U, Eigentler T, Keim U, et al. Primary Resistance to PD-1-Based Immunotherapy—A Study in 319 Patients with Stage IV Melanoma. Cancers. 2020; 12(4):1027. https://doi.org/10.3390/cancers12041027

Amaral, Teresa, Olivia Seeber, Edgar Mersi, Stephanie Sanchez, Ioannis Thomas, Andreas Meiwes, Andrea Forschner, Ulrike Leiter, Thomas Eigentler, Ulrike Keim, and et al. 2020. "Primary Resistance to PD-1-Based Immunotherapy—A Study in 319 Patients with Stage IV Melanoma" Cancers 12, no. 4: 1027. https://doi.org/10.3390/cancers12041027

Amaral, T., Seeber, O., Mersi, E., Sanchez, S., Thomas, I., Meiwes, A., Forschner, A., Leiter, U., Eigentler, T., Keim, U., & Garbe, C. (2020). Primary Resistance to PD-1-Based Immunotherapy—A Study in 319 Patients with Stage IV Melanoma. Cancers, 12(4), 1027. https://doi.org/10.3390/cancers12041027